MCP Server For Financial Data by EODHD Learn more

NEWRON PHARMACEUT. EO-20 (NP5 F) stock market data APIs

€25.3495 0.87(3.4%)
as of January 19, 2026
Try our APIs with free plan!

NEWRON PHARMACEUT. EO-20 Financial Data Overview

Price chart is built with Anychart
ISIN: IT000414**** The data is available with plans that include the Fundamentals API. Check our pricing page for details.

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company's lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. The company was founded in 1999 and is headquartered in Bresso, Italy.

Prev. Close 25.3495
Open 26.2219
High 26.5194
Low 24.7415
52 wk Range 5.91-33.55
Market Cap 517 M
P/E Ratio 19.0441
Shares Outstanding 19 961 K
Revenue 59 881 K
Beta 0.763

* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.


Why to choose EODHD?

Prices start at $19.99

24/7 Live support

Robust, powerful and reliable data

API Simplicity of a few lines of code


Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW

Get NEWRON PHARMACEUT. EO-20 data using free add-ons & libraries


Get NEWRON PHARMACEUT. EO-20 Fundamental Data

NEWRON PHARMACEUT. EO-20 Fundamental data includes:

  • Net Revenue: 59 881 K
  • EBITDA: 35 214 K
  • Earnings Per Share:
  • Income Statements
  • Balance Sheets
  • Cash flows

Plans with Fundamental data

Starting from

$ 59.99 /mo.
COMPARE PLANS

End-of-day & Earnings data

Get NEWRON PHARMACEUT. EO-20 Earnings data

Calendar & News package for

$ 19.99 /mo.

What’s included:

  • Latest Release: NaN
  • EPS/Forecast: NaN
GET THE PACKAGE

Get NEWRON PHARMACEUT. EO-20 End-of-day data

EOD Historical Data package for

$ 19.99 /mo.

What’s included:

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
GET THE PACKAGE
Try our APIs
with free plan!

Or get access to advanced financial data starting only $19.99

TRY NOW
  • Flexibility: No long-term commitments, just a minimum of one month
  • Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.

What’s included:

  • API Calls per Day: 100 000/day
  • API Requests per Min.: 1000/minute
  • Type of Usage: Personal use

Data access:

Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.

GET THE PACKAGE
Chat

Send the request

Leave your email and our team will contact you ASAP.